A detailed history of Los Angeles Capital Management LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 20,660 shares of VCYT stock, worth $930,939. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,660
Previous 20,910 1.2%
Holding current value
$930,939
Previous $453,000 55.19%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$21.0 - $35.25 $5,250 - $8,812
-250 Reduced 1.2%
20,660 $703,000
Q1 2024

Apr 05, 2024

BUY
$21.0 - $29.1 $237,363 - $328,917
11,303 Added 117.65%
20,910 $463,000
Q4 2023

Feb 06, 2024

BUY
$19.72 - $28.68 $189,450 - $275,528
9,607 New
9,607 $264,000
Q2 2022

Aug 05, 2022

BUY
$15.45 - $29.52 $413,272 - $789,630
26,749 New
26,749 $532,000
Q1 2022

May 06, 2022

SELL
$21.94 - $42.51 $130,499 - $252,849
-5,948 Closed
0 $0
Q4 2021

Feb 03, 2022

SELL
$36.09 - $53.79 $2,057 - $3,066
-57 Reduced 0.95%
5,948 $245,000
Q3 2021

Nov 08, 2021

BUY
$35.62 - $52.97 $4,630 - $6,886
130 Added 2.21%
6,005 $279,000
Q2 2021

Aug 05, 2021

SELL
$32.94 - $56.62 $9,882 - $16,986
-300 Reduced 4.86%
5,875 $235,000
Q1 2021

May 05, 2021

BUY
$44.47 - $81.38 $274,602 - $502,521
6,175 New
6,175 $331,000
Q4 2019

Feb 07, 2020

SELL
$20.78 - $29.99 $270,867 - $390,919
-13,035 Closed
0 $0
Q3 2019

Nov 07, 2019

BUY
$23.87 - $30.93 $35,805 - $46,395
1,500 Added 13.0%
13,035 $313,000
Q2 2019

Jul 29, 2019

BUY
$22.1 - $28.56 $8,619 - $11,138
390 Added 3.5%
11,535 $329,000
Q4 2018

Feb 11, 2019

BUY
$9.15 - $14.85 $101,976 - $165,503
11,145 New
11,145 $140,000

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $3.23B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.